Avant Diagnostics, Inc Deferred Tax Assets, Valuation Allowance
Avant Diagnostics, Inc had Deferred Tax Assets, Valuation Allowance of $12.86 million as of 2018-09-30, per its 10-K filed 2019-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2019-03-01
- 2018-09-30: Deferred Tax Assets, Valuation Allowance $12.86M.
- 2017-09-30: Deferred Tax Assets, Valuation Allowance $11.93M.
- 2016-09-30: Deferred Tax Assets, Valuation Allowance $5.91M.
- 2015-09-30: Deferred Tax Assets, Valuation Allowance $1.59M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2018-09-30 | $12.86M 10-K · filed 2019-03-01 |
| 2017-09-30 | $11.93M 10-K · filed 2019-03-01 |
| 2016-09-30 | $5.91M 10-K · filed 2018-12-04 |
| 2015-09-30 | $1.59M 10-K · filed 2018-08-28 |
| 2014-10-31 | $1.08M 10-K · filed 2015-02-12 |
| 2013-10-31 | $1.07M 10-K · filed 2015-02-12 |
| 2012-10-31 | $961.40K 10-K · filed 2013-02-14 |
| 2011-10-31 | $276.30K 10-K · filed 2013-02-14 |